Table 3.
NRF2 activators
Compound | References |
---|---|
Dithiolethiones (oltipraz) |
Ansher et al., 1986; Kwak et al., 2001; Pietsch et al., 2003; Ramos-Gomez et al., 2001; Iida et al., 2004 |
Isothiocyanates (sulphoraphan) |
Heiss et al., 2001; Brigelius-Flohe and Banning, 2006; Dinkova-Kostova et al., 2004; Fahey et al., 1997; Gerhauser et al., 1997; Hu et al., 2006; Juge et al., 2007; Zhang et al., 1994; Campbell et al., 2004; Clinton et al., 1996; Chiao et al., 2004; Giovannucci et al., 1995; Hecht et al., 1995; Lii et al., 2010; Miller et al., 2002 |
Triterpenoids (bardoxolone methyl) |
Dinkova-Kostova et al., 2001; Yates et al., 2007 |
Curcumin | Shen et al., 2006 |
Resveratrol | Leifert and Abeywardena, 2008; Udenigwe et al., 2008 |
Ethoxyquindiet | Cabral and Neal, 1983; Nair et al., 2006 |
Methyl ester and ethyl amide | Yates et al., 2007 |
Piceatannol | Lee et al., 2010a |
Simvastatin | Chartoumpekis et al., 2010 |
Metformin | Onken and Driscoll, 2010 |
Abbreviation: NRF2, NF-E2-related factor.